MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ZNTL Zentalis Pharmaceuticals
- 3.000
- +0.070+2.39%
Close Dec 20 16:00 ET
- 3.000
- 0.0000.00%
Post 20:01 ET
213.80MMarket Cap-1.20P/E (TTM)
3.100High2.890Low1.85MVolume2.900Open2.930Pre Close5.57MTurnover3.59%Turnover RatioLossP/E (Static)71.27MShares18.07052wk High0.60P/B154.86MFloat Cap2.66052wk Low--Dividend TTM51.62MShs Float87.190Historical High--Div YieldTTM7.17%Amplitude2.660Historical Low3.006Avg Price1Lot Size
Zentalis Pharmaceuticals Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 16, 2024
The average Zentalis Pharmaceuticals stock price target is 10.60 with a max estimate of 20.00 and a min estimate of 8.00
Review Zentalis Pharmaceuticals earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 16, 2024